rs141187241
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 8P and 4B. PVS1BS2
The NM_002471.4(MYH6):c.346-2A>G variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000192 in 1,613,984 control chromosomes in the GnomAD database, with no homozygous occurrence. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_002471.4 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYH6 | NM_002471.4 | c.346-2A>G | splice_acceptor_variant, intron_variant | Intron 4 of 38 | ENST00000405093.9 | NP_002462.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYH6 | ENST00000405093.9 | c.346-2A>G | splice_acceptor_variant, intron_variant | Intron 4 of 38 | 5 | NM_002471.4 | ENSP00000386041.3 | |||
MYH6 | ENST00000557461.2 | n.413-2A>G | splice_acceptor_variant, intron_variant | Intron 4 of 13 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152190Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251346Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135884
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1461794Hom.: 0 Cov.: 34 AF XY: 0.00000550 AC XY: 4AN XY: 727202
GnomAD4 genome AF: 0.000125 AC: 19AN: 152190Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74348
ClinVar
Submissions by phenotype
not provided Uncertain:2
Identified in at least one patient with peripartum cardiomyopathy in published literature (PMID: 33874732, 26735901); Canonical splice site variant in a gene or region of a gene for which loss of function is not a well-established mechanism of disease; This variant is associated with the following publications: (PMID: 33874732, 26735901) -
- -
not specified Uncertain:1
The 346-2A>G variant in MYH6 has not been previously reported in individuals wit h cardiomyopathy, but has been identified in 2/4406 of African American chromoso mes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; db SNP rs141187241). This variant occurs in the invariant region (+/- 1,2) of the s plice consensus sequence and is predicted to cause altered splicing leading to a n abnormal or absent protein. The MYH6 gene has been implicated in the etiology of HCM and DCM (Carniel 2005) as well as ASD (Granados-Riveron 2010) though the overall evidence is modest at this point. To date, 1 splice variant has been re ported in an individual with ASD (Granados-Riveron 2010). In summary, the clinic al significance of the 346-2A>G variant is uncertain. -
Hypertrophic cardiomyopathy 14 Uncertain:1
This sequence change affects an acceptor splice site in intron 4 of the MYH6 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), however the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in MYH6 cause disease. This variant is present in population databases (rs141187241, gnomAD 0.03%). Disruption of this splice site has been observed in individual(s) with peripartum cardiomyopathy (PMID: 26735901, 33874732). ClinVar contains an entry for this variant (Variation ID: 164255). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
MYH6-related disorder Uncertain:1
The MYH6 c.346-2A>G variant is predicted to disrupt the AG splice acceptor site and interfere with normal splicing. This variant has been reported in a peripartum cardiomyopathy cohort (Table S2, Ware et al. 2016. PubMed ID: 26735901; Table S2, Goli et al. 2021. PubMed ID: 33874732). This variant was also reported in a case of non‑ischemic sudden cardiac death with the autopsy findings of left ventricular hypertrophy and myocardial fibrosis (Holmström et al. 2021. PubMed ID: 34045587). This variant is reported in 0.032% of alleles in individuals of African descent in gnomAD and is interpreted as uncertain significance in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/164255/). Loss of function has not been established as a mechanism for MYH6-related disorders. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Cardiovascular phenotype Uncertain:1
The c.346-2A>G intronic variant results from an A to G substitution two nucleotides before coding exon 3 of the MYH6 gene. This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will weaken the native splice acceptor site and will result in the creation or strengthening of a novel splice acceptor site. Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. However, loss of function of MYH6 has not been clearly established as a mechanism of disease. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at